PRIME study: Aducanumab in Alzheimer’s disease
PRIME study: Aducanumab in Alzheimer’s disease
PRIME study: Aducanumab in Alzheimer’s disease
https://twitter.com/PANA_PROJECT
On the 25th and 26th April 2016 the first meeting of the PANA consortium took place, in Santiago de Compostela, hosted by Servizo Galego de Saúde (SERGAS) as the project’s coordinating institution.